< Back

Gain complete end-to-end visibility over your supply chain: why both S-data and O-data are needed

During the past two decades, the value of pharmaceutical goods traded globally has grown sixfold, from $113 billion in 2000 to $629 billion in 2019¹. As a result of this growth, supply chains have become increasingly global and complex, with current regulations being too focused on managing a ‘black box’ without visibility on the status of the shipment.